权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Fast 3D MR Spectroscopic Imaging of Human Breast Cancer

人类乳腺癌的快速 3D MR 光谱成像

基本信息

批准号：
7591135
负责人：
QIUHONG HE
金额：
$ 27.14万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-06-01 至 2012-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7591135
关键词：
Adopted Animal Model Antineoplastic Agents Benign Biochemical Biological Markers Biopsy Breast Breast Cancer Early Detection Breast Cancer Treatment Cancer Patient Cancerous Cells Characteristics Chemicals Choline Clinical Clinical Protocols Clinical effectiveness Data Detection Development Diagnosis Diagnostic Diagnostic Specificity Effectiveness Grant Human Human Volunteers Image Imaging Techniques Investigation Laboratories Lipids Magnetic Resonance Imaging Magnetic Resonance Spectroscopy Malignant - descriptor Malignant Neoplasms Malignant neoplasm of prostate Mammary Gland Parenchyma Maps Measurement Metabolic Metabolic Marker Metabolism Methods Pathway interactions Patients Penetration Physiologic pulse Problem Solving Proliferating Protons Relaxation Research Personnel Resolution Scanning Sensitivity and Specificity Signal Transduction Slice Spatial Distribution Specificity Staging Techniques Testing Time Tissues Treatment Protocols Unsaturated Fats Water base brain research breast cancer diagnosis breast lesion cancer diagnosis clinical Diagnosis imaging modality improved in vivo iproplatin malignant breast neoplasm molecular marker novel outcome forecast peroxidation programs quantum research study response spectroscopic imaging tool tumor

项目摘要

DESCRIPTION (provided by applicant): Malignant tumor metabolism including lipid sysnthesis and peroxidation differs from normal breast tissue and benign tumors. Some of these biochemical changes can be detected by proton MR spectroscopic imaging (MRSI) using lactate, choline, and unsaturated lipid as molecular markers of breast cancer for clinical diagnosis and prognosis. The proton NMR detection of metabolites in breast tissue, however, has been challenging due to the intense lipid and water signals that block the observation of low concentration of metabolites in breast tissue. The recent advances in magnetic resonance spectroscopy permits the detection of elevated choline level in malignant breast tumors, reflecting the rapid phosphblipid synthesis and high metabolic activities of the proliferating cells. We have developed the Sel-MQC MRSI methods to observe lactate and unsaturated lipid changes in clinical breast cancer, which eliminate lipid and water signals in a single scan by multiple quantum filtering. In this grant period, we will develop novel fast Sel-MQC techniques to improve the temporal resolution of the Sel-MQC MRSI for clinical breast cancer diagnosis. The following specific aims will be achieved: (1) To improve clinical MR diagnostic specificity of human breast cancer using the novel Sel-MQC sequences for simultaneous mapping of choline, lactate, and unsaturated lipid signals; (2) To develop fast 3D MRSI methods and improve the temporal resolution for quantitative Sel-MQC mapping of lactate, choline, and unsaturated lipid -in breast tissues. Clinical protocols will be developed to quantitatively evaluate lactate and choline, and unsaturated lipid as molecular markers of breast caner using the Sel-MQC methods on 3T clinical MRI scanners. We will studyapproximately 30 patients/yr for those who are undergoing breast MRI imaging and subsequent biopsy. The MRSI spectral data will be compared with the pathological diagnosis to determine the potential of the technique. This project will demonstrate the clinical effectiveness of MRSI as a non-invasive method using biomolecular markers for early detection of breast cancer with potentially high diagnostic specificity and sensitivity. If successful, the proton MRSI will also provide a method to evaluate responses to the breast cancer treatment regimens, as well as diagnostic tool for other extracranial cancers.

描述（由申请人提供）：